A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies
Open Access
- 1 June 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (6), 1918-1936
- https://doi.org/10.1210/clinem/dgz326
Abstract
Context As many as 75% of patients with Polycystic ovary syndrome (PCOS) are estimated to be unidentified in clinical practice. Objective Utilizing polygenic risk prediction, we aim to identify the phenome-wide comorbidity patterns characteristic of PCOS to improve accurate diagnosis and preventive treatment. Design, Patients, and Methods Leveraging the electronic health records (EHRs) of 124,852 individuals, we developed a PCOS risk prediction algorithm by combining polygenic risk scores (PRS) with PCOS component phenotypes into a polygenic and phenotypic risk score (PPRS). We evaluated its predictive capability across different ancestries and perform a PRS-based phenome-wide association study (PheWAS) to assess the phenomic expression of the heightened risk of PCOS. Results The integrated polygenic prediction improved the average performance (pseudo-R2) for PCOS detection by 0.228 (61.5-fold), 0.224 (58.8-fold), 0.211 (57.0-fold) over the null model across European, African, and multi-ancestry participants respectively. The subsequent PRS-powered PheWAS identified a high level of shared biology between PCOS and a range of metabolic and endocrine outcomes, especially with obesity and diabetes: ‘morbid obesity’, ‘type 2 diabetes’, ‘hypercholesterolemia’, ‘disorders of lipid metabolism’, ‘hypertension’ and ‘sleep apnea’ reaching phenome-wide significance. Conclusions Our study has expanded the methodological utility of PRS in patient stratification and risk prediction, especially in a multifactorial condition like PCOS, across different genetic origins. By utilizing the individual genome-phenome data available from the EHR, our approach also demonstrates that polygenic prediction by PRS can provide valuable opportunities to discover the pleiotropic phenomic network associated with PCOS pathogenesis.Keywords
Funding Information
- National Institutes of Health
- National Human Genome Research Institute (U01HG008657)
- Kaiser Permanente
- University of Washington School of Medicine
- Brigham and Women's Hospital (U01HG008685)
- Vanderbilt University Medical Center (U01HG008672)
- Cincinnati Children's Hospital Medical Center (U01HG008666)
- Mayo Clinic (U01HG006379)
- Geisinger Clinic (U01HG008679)
- Columbia University Health Sciences (U01HG008680)
- Children's Hospital of Philadelphia (U01HG008684)
- Northwestern University (U01HG008673)
- Vanderbilt University Medical Center (U01HG008701)
- Partners Healthcare (U01HG008676)
- Broad Institute
- Baylor College of Medicine (U01HG008664)
This publication has 50 references indexed in Scilit:
- Genome-wide association study identifies eight new risk loci for polycystic ovary syndromeNature Genetics, 2012
- Electronic Medical Records for Genetic Research: Results of the eMERGE ConsortiumScience Translational Medicine, 2011
- The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studiesBMC Medical Genomics, 2011
- PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associationsBioinformatics, 2010
- Common disorders are quantitative traitsNature Reviews Genetics, 2009
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorderNature, 2009
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesAmerican Journal of Human Genetics, 2007
- Overcoming the Winner’s Curse: Estimating Penetrance Parameters from Case-Control DataAmerican Journal of Human Genetics, 2007
- Polycystic Ovary SyndromeObstetrical & Gynecological Survey, 1999